Artivion Announces U.S. FDA Approval of the AMDS Hybrid Prosthesis

Go back to Artivion Announces U.S. FDA Approval of the AMDS Hybrid Prosthesis
(NYSE: AORT) Delayed: 26.77 +0.10 (0.37%)
Previous Close $26.67    52 Week High
Open $26.71    52 Week Low
Day High $27.11    P/E N/A 
Day Low $26.69    EPS
Volume 466,496